Celecoxib and Myrtol: A Novel Therapy for Recurrent Appendiceal Mucinous Neoplasms With Extensive Peritoneal Dissemination.

Celecoxib and Myrtol: A Novel Therapy for Recurrent Appendiceal Mucinous Neoplasms With Extensive Peritoneal Dissemination. Am J Clin Oncol. 2022 01 01; 45(1):9-13.

View in: PubMed

subject areas

Administration, Oral
Aged
Antineoplastic Combined Chemotherapy Protocols
Appendiceal Neoplasms
Carcinoembryonic Antigen
Celecoxib
Cytoreduction Surgical Procedures
Drug Combinations
Female
GPI-Linked Proteins
Humans
Male
Middle Aged
Monoterpenes
Neoplasm Recurrence, Local
Peritoneal Neoplasms
Retrospective Studies
Treatment Outcome

authors with profiles

Blase Polite
Ardaman Shergill